Information on SCID11
Basic details
Name: Severe combined immunodeficiency, Athabascan type | Acronym: SCID11
Alt. names: ARTEMIS deficiency
Gene: DCLRE1C | MOI: Autosomal recessive | Mechanism of action:
No. of cases in DB: 0 | First reported in: 2001
Last updated on: 2023-02-28 16:41:18 by
Description
It is characterized by the classic symptoms of SCID, such as growth retardation, severe infections (pneumonia, gastrointestinal infections, sepsis), recurrent or persistent thrush, and chronic diarrhea. Maternal-fetal transfusion-associated graft-versus-host disease is also associated with the disease. Immunologic findings include the absence of T and B lymphocytes with a normal count of other immune cells, such as NK lymphocytes.
Management
The main treatment is based on immunosuppressants (such as prednisone and cyclosporine), followed by a hematopoietic stem cell transplant. Prophylaxis against infections and their early and aggressive treatment are the best way to avoid the complications derived from them.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.